Seres therapeutics to participate in cowen 42nd annual health care conference

Cambridge, mass.--(business wire)--seres therapeutics, inc. (nasdaq: mcrb), a leading microbiome therapeutics company, today announced that eric shaff, president and chief executive officer of seres therapeutics, will participate in a panel discussion at the cowen 42nd annual health care conference on wednesday, march 9, 2022 at 10:30 a.m. et. an audio webcast of the panel discussion will be available under the “investors and media” section of seres' website. a replay of the presentation will b
MCRB Ratings Summary
MCRB Quant Ranking